A novel inhibitor of IL-1 generation, E5090: in vivo inhibitory effect on the generation of IL-1-like factor and on granuloma formation in an air-pouch model

Agents Actions Suppl. 1991:32:231-5. doi: 10.1007/978-3-0348-7405-2_31.

Abstract

The in vivo production of IL-1-like activity was investigated in the exudate of a rat air-pouch inflammatory model. An inflammatory reaction was induced by LPS injection into the air-pouch. IL-1 activity in the exudate reached the maximum level at 4 h and then rapidly decreased until 8 h after the injection of LPS. Orally administered E5090 and prednisolone dose-dependently inhibited the generation of IL-1 activity. Both compounds also suppressed chronic granuloma formation in parallel with the IL-1 inhibition. On the other hand, indomethacin had no effect on either IL-1 generation or granuloma formation in spite of the complete inhibition of PGE2 generation. These results suggest that E5090 inhibits the production of IL-1-like activity in the exudate and exhibits steroid-like antiinflammatory effects.

MeSH terms

  • Acrylates / pharmacology*
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Dinoprostone / metabolism
  • Exudates and Transudates / cytology
  • Exudates and Transudates / metabolism
  • Granuloma / metabolism
  • Granuloma / prevention & control*
  • Indomethacin / pharmacology
  • Interleukin-1 / biosynthesis*
  • Male
  • Naphthols / pharmacology*
  • Orosomucoid / biosynthesis
  • Prednisolone / pharmacology
  • Rats
  • Rats, Inbred F344

Substances

  • Acrylates
  • Anti-Inflammatory Agents, Non-Steroidal
  • Interleukin-1
  • Naphthols
  • Orosomucoid
  • E 5090
  • Prednisolone
  • Dinoprostone
  • Indomethacin